Revenue Ahead of Expectations
First quarter 2026 revenue of $88.0 million came in ahead of company expectations despite year-over-year pressure; management emphasized quality over volume for 2026.
Improved Medicare Unit Economics
Medicare LTV to CAC ratio improved to 1.4x, a 17% improvement from 1.2x a year ago; Medicare MA LTV increased 3% year-over-year and total acquisition cost per MA equivalent approved member declined 10%.
Lowered Variable Marketing Costs and Better Channel Mix
Variable marketing cost per MA equivalent approved member declined 28%; non-GAAP marketing & advertising expense declined 38% (variable marketing down 44%), reflecting disciplined demand generation and a shift toward higher-quality branded channels.
Margin Expansion in Medicare Segment
Medicare segment gross profit was $33 million (down 8% YoY), but gross profit margin widened materially from 34% to 41%, driven by improved LTV-to-CAC and higher-quality enrollments.
Adjusted EBITDA and Positive Operating Cash Flow Start
First quarter adjusted EBITDA was $9.0 million (exceeding internal plan) and operating cash flow was positive at $35.8 million, both highlighted as evidence of progress toward the company’s cash-flow-focused 2026 plan.
Fixed Cost Reductions and Expense Discipline
Management implemented headcount reductions and vendor consolidations expected to reduce fixed operating costs by approximately $30 million in 2026 (~20% reduction vs. 2025); non-GAAP total operating expenses (ex-SBC and restructuring) declined 21% to $82.3 million.
Product & Operating-Model Initiatives Launched
Company prepared and launched its lifetime advisory model and introduced final expense insurance in April; new agent-facing tech tools (member dashboard, system recommendations, dynamic scripts) are intended to drive retention and cross-sell.
Improved Lifetime Values Across Products
First quarter lifetime values increased: Medicare Advantage +3%, Medicare Supplement +19%, PDP +78%, supporting the case for higher-quality enrollments and cross-sell economics.
Strong Balance Sheet and Growing Commission Receivable
Cash, cash equivalents and short-term marketable securities totaled $110.8 million at quarter-end; commission receivable value grew to just over $1.0 billion, a 12% increase YoY (from $923 million).
3-Year Targets Toward Profitability and Growth
Updated 3-year outlook targets a return to revenue growth in 2027 (mid-single-digit) and mid-teens growth in 2028, adjusted EBITDA margin expansion to ~20% by 2028, and breakeven or better free cash flow in 2027.